FYERS
Kimia Biosciences30.95
+1.56 (+5.31%)

Kimia Biosciences Share Price

30.95+1.56 (+5.31%)
-17.42% past 1 Year

Corporate filings & documents

Announcements

Submission of Newspaper cutting of publication of 33rd AGM Notice of Kimia Biosciences Limited confirming dispatch of AGM Notice of the Company
2 weeks ago
Submission of Newspaper cutting of publication of 33rd AGM Notice of Kimia Biosciences Limited confirming dispatch of AGM Notice of the Company
2 weeks ago
Thirty Third Annual Report for the Financial Year 2025-2026 of Kimia Biosciences Limited
2 weeks ago
Intimation of Cut off Date/ Record Date E-Voting and AGM date for the 33rd Annual General Meeting
2 weeks ago
Intimation of Cut off Date/ Record Date E-Voting and AGM date for the 33rd Annual General Meeting
2 weeks ago
Submission of Pre dispatch Newspaper Advertisement of ensuing 33rd AGM to be held on 28 September 2026 at 3.00 P.M. through Video Conferencing/ other audio Visual Means (VC/OAVM)
2 weeks ago
Submission of Pre dispatch Newspaper Advertisement of ensuing 33rd AGM to be held on 28 September 2026 at 3.00 P.M. through Video Conferencing/ other audio Visual Means (VC/OAVM)
2 weeks ago
Intimation of 33rd Annual General Meeting of the Company proposed to be held on September 28 2026 at 03:00 P.M. through Video Conferencing/ Other Audio Visual Means.
2 weeks ago
Intimation of 33rd Annual General Meeting of the Company proposed to be held on September 28 2026 at 03:00 P.M. through Video Conferencing/ Other Audio Visual Means.
2 weeks ago
Outcome of the Meeting of the Board of Directors held on September 03 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 weeks ago
Outcome of the Meeting of the Board of Directors held on September 03 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015.
2 weeks ago
Newspaper publication unaudited Financial Results for the Quarter Ended 30 June 2026
1 month ago
Newspaper publication unaudited Financial Results for the Quarter Ended 30 June 2026
1 month ago
Approval of unaudited financial result (Standalone) for quarter ended june 30 2026.
1 month ago
Approval of unaudited financial result (Standalone) for quarter ended june 30 2026.
1 month ago
Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:1. Unaudited Financial Results for the First quarter ended June 30 2026 duly approved and taken on record by the Board of Directors at its meeting held today i.e. Monday August 10 2026. 2. Limited Review Report on the aforesaid results from Statutory Auditors of the Company as placed before the Board of Directors of the Company in its meeting held today.
1 month ago
Pursuant to Regulation 33 and 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 we have enclosed herewith:1. Unaudited Financial Results for the First quarter ended June 30 2026 duly approved and taken on record by the Board of Directors at its meeting held today i.e. Monday August 10 2026. 2. Limited Review Report on the aforesaid results from Statutory Auditors of the Company as placed before the Board of Directors of the Company in its meeting held today.
1 month ago
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026.
1 month ago
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 inter alia to consider and approve Un-Audited Financial Results (Standalone) for the first quarter ended on June 30th 2026.
1 month ago
Change in Management appointment of Cost Auditor Internal Auditor Secretarial Auditor and Discountinuance/ Cessation of Secretarial Auditor
1 month ago
Outcome of the Meeting of the Board of Directors held on August 1 2026 under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 - Appointment of Cost Auditor Internal Auditor and Secretarial Auditor and Discontinuance of Secretarial Auditor
1 month ago
Closure of Trading window for quarter ending June 30 2026
2 months ago
Closure of Trading window for quarter ending June 30 2026
2 months ago
Publication of Results for quarter and year ended March 31 2026
3 months ago
Publication of Results for quarter and year ended March 31 2026
3 months ago
Approval of Audited standalone Financial results alongwith Audited Report thereon for financial year 2025-26
3 months ago
Kimia Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone ) for the quarter and financial year ended 31st March 2026 along with the Audit Report thereon
4 months ago
Appointment of Mr. Mani Jain as CFO & KMP w.e.f. 27.04.2026
4 months ago
Appointment of Mr. Mani Jain as CFO & KMP w.e.f. 27.04.2026
4 months ago
Outcome of Board Meeting held on 18 April 2026 under regulation 30 of Sebi(Lodr) Regulations 2015 - Change in Management
5 months ago
Compliance certificate under Reg. 74(5) of SEBI (DP)Regulations 2018 for quarter ending March 31 2026.
5 months ago
We would like to inform you that company is in compliance with provision of Reg 30 of SEBI(LODR) Regulations 2015 and has been promptly intimating to exchange all events information and announcement that may have bearing on operation and performance of the company. There is no undisclosed price sensitive information or any pending announcement/corporate action which in our opinion may have a bearing on price movement in the scrip of the company. The movement in share price is purely market driven and company has no control over the same.
5 months ago
We would like to inform you that company is in compliance with provision of Reg 30 of SEBI(LODR) Regulations 2015 and has been promptly intimating to exchange all events information and announcement that may have bearing on operation and performance of the company. There is no undisclosed price sensitive information or any pending announcement/corporate action which in our opinion may have a bearing on price movement in the scrip of the company. The movement in share price is purely market driven and company has no control over the same.
5 months ago
The Exchange has sought clarification from Kimia Biosciences Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
The Exchange has sought clarification from Kimia Biosciences Ltd on April 13 2026 with reference to significant movement in price in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.<BR><BR>The reply is awaited.
5 months ago
Intimation of change of management under regulation 30 of SEBI LODR 2015
5 months ago
Intimation of change of management under regulation 30 of SEBI LODR 2015
5 months ago
Intimation of Resignation of Pallavi Garg as Company Secretary and Compliance officer of the company w.e.f. 03.04.2026.
5 months ago
Intimation of Resignation of Pallavi Garg as Company Secretary and Compliance officer of the company w.e.f. 03.04.2026.
5 months ago
Closure of Trading window
5 months ago
Closure of Trading window
5 months ago
Voting Result of Postal Ballot along with Scrutinizer Report
6 months ago
Resignation of Additional Director(in the category of Executive Director)
7 months ago
Newspaper Publication-Postal ballot
7 months ago
Newspaper Publication-Postal ballot
7 months ago
Intimation of postal ballot notice
7 months ago
Intimation under Regulation 30 of SEBI(Listing Obligations and Disclosures Requirement)Regulation 2015-modification in Postal Ballot notice
7 months ago
Newspaper Publication for the financial results for the quarter and nine months ended 31st December 2025
7 months ago
Newspaper Publication for the financial results for the quarter and nine months ended 31st December 2025
7 months ago
Results for the financial for the quarter and nine months ended on 31st December 2025
7 months ago

Annual reports

FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

Concalls & investor presentations

Empty box

No presentations found

Kimia Biosciences Ltd Share Price Today

The Kimia Biosciences Ltd share price today is ₹30.27. During the trading session, the Kimia Biosciences Ltd share price opened at ₹29.27 and recorded an intraday high of ₹30.27 and a low of ₹29.01. Last closing price was ₹29.27. Over the past 52 weeks, the Kimia Biosciences Ltd share price has ranged between ₹23.20 and ₹43.28. The current Kimia Biosciences Ltd stock price reflects real-time market activity based on executed trades on the exchange.